These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22440871)

  • 1. Pseudoprogression and treatment effect.
    Jahangiri A; Aghi MK
    Neurosurg Clin N Am; 2012 Apr; 23(2):277-87, viii-ix. PubMed ID: 22440871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
    Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
    J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
    Puchner MJ; Giese A; Lohmann F; Cristante L
    Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.
    Yun TJ; Park CK; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Choi SH
    Radiology; 2015 Mar; 274(3):830-40. PubMed ID: 25333475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.
    Stuplich M; Hadizadeh DR; Kuchelmeister K; Scorzin J; Filss C; Langen KJ; Schäfer N; Mack F; Schüller H; Simon M; Glas M; Pietsch T; Urbach H; Herrlinger U
    J Clin Oncol; 2012 Jul; 30(21):e180-3. PubMed ID: 22689800
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances that enable identification of glioblastoma recurrence.
    Yang I; Aghi MK
    Nat Rev Clin Oncol; 2009 Nov; 6(11):648-57. PubMed ID: 19806145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
    Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion?
    Stevens QE; Howes G; Dickerman RD; Lee JM; Nardone EM
    Clin Neurol Neurosurg; 2007 Feb; 109(2):195-9. PubMed ID: 17056178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant gliomas--radiotherapy].
    Schratter-Sehn A
    Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
    Deininger MH; Grote E; Wickboldt J; Meyermann R
    J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of evasion to antiangiogenic therapy in glioblastoma.
    Rose SD; Aghi MK
    Clin Neurosurg; 2010; 57():123-8. PubMed ID: 21280504
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudoprogression following concurrent temozolomide and radiotherapy in a patient with glioblastoma: findings on functional imaging techniques.
    Shirakawa Y; Yoshiura T; Hiwatashi A; Yamashita K; Kamano H; Shioyama Y; Abe K; Amano T; Nakamizo A; Yoshimoto K; Honda H; Torisu R; Suzuki S; Honda H
    Fukuoka Igaku Zasshi; 2010 Dec; 101(12):257-64. PubMed ID: 21476455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?
    Rieger J; Bähr O; Ronellenfitsch MW; Steinbach J; Hattingen E
    J Clin Oncol; 2010 Sep; 28(27):e477; author reply e478. PubMed ID: 20585096
    [No Abstract]   [Full Text] [Related]  

  • 15. Recognizing and correcting failures in glioblastoma treatment.
    Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ
    Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication for repeat surgery of glioblastoma: influence of progress of disease.
    Mühling M; Krage J; Hussein S; Samii M
    Front Radiat Ther Oncol; 1999; 33():192-201. PubMed ID: 10549489
    [No Abstract]   [Full Text] [Related]  

  • 17. In regard McDonald et al., to Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma (Int J Radiat Oncol Biol Phys 2011;79:130-136).
    Rogers S; Merlo A; Berberat J; Bodis S
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):316; author reply 316. PubMed ID: 21816295
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of relapsing glioblastoma multiforme responding to vinorelbine.
    Biassoni V; Casanova M; Spreafico F; Gandola L; Massimino M
    J Neurooncol; 2006 Nov; 80(2):195-201. PubMed ID: 16670944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report.
    Zhao M; Ma H; Cheng P; Yang H; Zhao Y; Han Q
    Medicine (Baltimore); 2022 Dec; 101(49):e32156. PubMed ID: 36626518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.
    Pinho MC; Polaskova P; Kalpathy-Cramer J; Jennings D; Emblem KE; Jain RK; Rosen BR; Wen PY; Sorensen AG; Batchelor TT; Gerstner ER
    Oncologist; 2014 Jan; 19(1):75-81. PubMed ID: 24309981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.